Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study
Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study have?
Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study has 5 citations in the OpenAlex counts ScholarIQ stores.
When was Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study published?
Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study has 2024 year in the ScholarIQ index.
What is the open-access status of Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study?
Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study has bronze oa status in the ScholarIQ index.
What is the DOI of Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study?
The DOI for Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study is on the source record.
What is the PMID of Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study?
The PMID for Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study is on the source record.
What is the OpenAlex record for Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study?
The OpenAlex for Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study is on the source record.